Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products.

This bill requires New Jersey health insurance plans to cover at least one abuse-deterrent opioid analgesic drug per active ingredient on their prescription formulary. It limits patient cost-sharing for these drugs to no more than the lowest cost-sharing level for equivalent non-abuse-deterrent opioids. The bill also prohibits prior authorization requirements from forcing patients to try non-abuse-deterrent opioids first before accessing abuse-deterrent options. This directly affects health insurers (carriers) and patients prescribed opioid pain medications for moderate to severe pain.